Literature DB >> 12718655

Genotype Frequencies of Cyclooxygenease 2 (COX2) Rare Polymorphisms for Japanese with and without Colorectal Cancer.

Nobuyuki Hamajima1, Toshiro Takezaki, Keitaro Matsuo, Toshiko Saito, Manami Inoue, Takashi Hirai, Tomoyuki Kato, Junko Ozeki, Kazuo Tajima.   

Abstract

Cyclooxygenase 2 (COX2) is an inducible enzyme synthesizing prostaglandins from arachidonic acid, which is thought to play an important role in colorectal carcinogenesis. Since the COX2 polymorphisms, if functional, may modify the carcinogenesis pathway, the associations between the reported polymorphisms and colorectal cancer risk were examined in a hospital-based case-control study. Six polymorphisms of the gene encoding COX2 were genotyped for 241 non-cancer individuals (controls) and 148 colorectal cancer patients (74 colon cancer, 73 rectal cancer, and 1 colorectal cancer date, 22 polymorphisms including the above six have been reported for COX2. The other polymorphisms remain to be examined.

Entities:  

Year:  2001        PMID: 12718655

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  16 in total

1.  COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations.

Authors:  Karen W Makar; Elizabeth M Poole; Alexa J Resler; Brenna Seufert; Karen Curtin; Sarah E Kleinstein; David Duggan; Richard J Kulmacz; Li Hsu; John Whitton; Christopher S Carlson; Christine F Rimorin; Bette J Caan; John A Baron; John D Potter; Martha L Slattery; Cornelia M Ulrich
Journal:  Cancer Causes Control       Date:  2013-12       Impact factor: 2.506

2.  Cyclooxygenase-2 polymorphisms and breast cancer associated risk in Pakistani patients.

Authors:  Tariq Moatter; Muniba Aban; Waseem Iqbal; Shahid Pervez
Journal:  Pathol Oncol Res       Date:  2014-05-03       Impact factor: 3.201

3.  Polymorphic human prostaglandin H synthase-2 proteins and their interactions with cyclooxygenase substrates and inhibitors.

Authors:  W Liu; E M Poole; C M Ulrich; R J Kulmacz
Journal:  Pharmacogenomics J       Date:  2010-06-15       Impact factor: 3.550

4.  Association of COX2 -765G>C promoter polymorphism and coronary artery disease in Korean population.

Authors:  In Jai Kim; Sang Hoon Kim; Dong Hoon Cha; Sang Wook Lim; Jae Youn Moon; Jung Oh Kim; Chang Soo Ryu; Han Sung Park; Jung Hoon Sung; Nam Keun Kim
Journal:  Genes Genomics       Date:  2019-06-05       Impact factor: 1.839

5.  Cyclooxygenase-2 gene polymorphisms and the risk of colorectal cancer: A population-based study.

Authors:  Hongxia Li; Qinyue Guo; Bo Zhou; Shuixiang He
Journal:  Oncol Lett       Date:  2015-07-09       Impact factor: 2.967

6.  -765G>C and 8473T>C polymorphisms of COX-2 and cancer risk: a meta-analysis based on 33 case-control studies.

Authors:  Wei Zhu; Bing-bing Wei; Xia Shan; Ping Liu
Journal:  Mol Biol Rep       Date:  2009-08-09       Impact factor: 2.316

7.  Role of cyclooxygenase-2 functional gene polymorphisms in Helicobacter pylori induced gastritis and gastric atrophy.

Authors:  B R Achyut; Uday C Ghoshal; Nikhil Moorchung; Balraj Mittal
Journal:  Mol Cell Biochem       Date:  2008-09-30       Impact factor: 3.396

8.  Functional polymorphisms of the cyclooxygenase (PTGS2) gene and risk for gallbladder cancer in a North Indian population.

Authors:  Kshitij Srivastava; Anvesha Srivastava; Sachchida Nand Pandey; Ashok Kumar; Balraj Mittal
Journal:  J Gastroenterol       Date:  2009-05-20       Impact factor: 7.527

9.  PTGS2 (COX-2) -765 G > C functional promoter polymorphism and its association with risk and lymph node metastasis in nasopharyngeal carcinoma.

Authors:  Hela Ben Nasr; Karim Chahed; Noureddine Bouaouina; Lotfi Chouchane
Journal:  Mol Biol Rep       Date:  2007-10-30       Impact factor: 2.316

10.  Polymorphism of -765G > C COX-2 is a risk factor for gastric adenocarcinoma and peptic ulcer disease in addition to H pylori infection: a study from northern India.

Authors:  Ashish Saxena; Kashi-Nath Prasad; Uday-Chand Ghoshal; Monty-Roshan Bhagat; Narendra Krishnani; Nuzhat Husain
Journal:  World J Gastroenterol       Date:  2008-03-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.